Le Lézard
Classified in: Health
Subject: FDA

KOAG Receives FDA Clearance for Vascette® HP Hemostatic Pad for Vascular Closure


MINNEAPOLIS, Aug. 22, 2022 /PRNewswire/ -- KOAG LLC, a Minneapolis-based medical device firm engaged in the design of innovative, topical vascular closure systems, announced today it received FDA clearance for its Vascette® HP device.

Vascette® is a unique, topical closure pad incorporating a proprietary, plant-derived hemostatic foam. The Vascette® patent-pending technology supports rapid hemostasis (blood stoppage) after cardiac catheterization without direct compression over the arterial puncture site (arteriotomy). 

KOAG will exhibit the Vascette® HP at the Association for Vascular Access (AVA) congress in Minneapolis, September 30-Oct 2.

KOAG LLC is a privately held medical device organization headquartered in suburban Minneapolis, MN.

SOURCE KOAG LLC


These press releases may also interest you

at 07:50
Calyx Medical Imaging Supports Groundbreaking Melanoma Treatment Approval
Calyx, a leading technology-enabled provider of Medical Imaging services and IRT/RTSM (Interactive Response Technology/Randomized Trial Supply Management) today announced its role in supporting the imaging-based endpoint for the pivotal trial that...

at 07:45
Endo Launches Enhanced TruDelivery® Ready-to-Use Product Line and Platform
Endo, Inc. announced today that its Endo Injectable Solutions business unit launched its enhanced ready-to-use product line and platform, TruDelivery®, underscoring the company's commitment to building its ready-to-administer and ready-to-use...

at 07:35
Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other Indications
Gossamer Bio, Inc. ("Gossamer") , a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary hypertension, and Chiesi Farmaceutici S.p.A ("Chiesi Group"), an...

at 07:30
Quipt Home Medical Corp. to Announce Fiscal Second Quarter 2024 Financial Results on May 15, 2024
Quipt Home Medical Corp. (the "Company") , a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal second quarter 2024 financial results on Wednesday, May 15, 2024. Gregory Crawford, Chief...

at 07:30
Spectral Medical Provides April Tigris Trial Update
Spectral Medical Inc. ("Spectral" or the "Company") , a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided an update on the Company's Tigris trial, a Phase 3 follow-on study evaluating the use of...

at 07:30
Soligenix to Present at Upcoming Conferences
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the Company will deliver a...

More news about Health...


News published on and distributed by: